Filtros de búsqueda

Lista de obras de

A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer

artículo científico publicado en 2016

Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience

artículo científico publicado en 2014

Clinical Decision Making: Integrating Advances in the Molecular Understanding of Spine Tumors

artículo científico publicado en 2016

Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"

scientific article published on 27 August 2019

Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion

artículo científico publicado en 2017

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

artículo científico publicado en 2016

Immuno-genomic landscape of osteosarcoma

scientific article published on 21 February 2020

MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma

artículo científico publicado en 2019

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes

artículo científico publicado en 2017

PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma

scientific article published on 29 May 2020

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

artículo científico

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda